Syneos Health Schedules Third Quarter 2022 Earnings Call for Friday, November 4, 2022
Syneos Health (Nasdaq:SYNH) will announce its Q3 2022 financial results on November 4, 2022, before an earnings call at 8:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Syneos Health (Nasdaq:SYNH) will announce its Q3 2022 financial results on November 4, 2022, before an earnings call at 8:00 a.m. ET. Participants can join the call by registering in advance through their website. A replay of the webcast will be accessible after 1:00 p.m. on the same day. Syneos Health, a fully integrated biopharmaceutical solutions organization, employs over 29,000 professionals across 110 countries, focusing on improving the delivery of therapies to patients through advanced integration of clinical, medical, and commercial capabilities.
Positive
- Syneos Health employs over 29,000 professionals, enhancing its operational capacity.
- The company integrates clinical development, medical affairs, and commercial capabilities to streamline therapy delivery.
Negative
- None.
Details
News Market Reaction – SYNH
The recorded move for SYNH in the trading session of this news was +0.02%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MORRISVILLE, N.C., Oct. 21, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2022 financial results on Friday, November 4, 2022, prior to its earnings call at 8:00 a.m. ET.
To listen only and view the presentation slides via the live webcast, join from the Investor Relations section of the Syneos Health website at investor.syneoshealth.com.
To participate in the conference, please register in advance at this link. Upon registration, all participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on November 4, 2022.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically integrating clinical development, medical affairs and commercial capabilities to address modern market realities.
We bring together more than 29,000 minds, across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
| Investor Relations Contact: | Press/Media Contact: |
| Ronnie Speight | Gary Gatyas |
| Senior Vice President, Investor Relations | Executive Director, External Communications |
| +1 919 745 2745 | +1 908 763 3428 |
| Investor.Relations@syneoshealth.com | gary.gatyas@syneoshealth.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.